The Significance of Microvascular Inflammation in Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.

被引:0
|
作者
Ishihara, H. [1 ]
Ishida, H. [1 ]
Unagami, K. [2 ]
Hirai, T. [1 ]
Okumi, M. [1 ]
Omoto, K. [1 ]
Shimizu, T. [1 ]
Tanabe, K. [1 ]
机构
[1] Tokyo Womens Med Univ, Urol, Tokyo, Japan
[2] Tokyo Womens Med Univ, Nephrol, Tokyo, Japan
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
C3
引用
收藏
页码:601 / 602
页数:2
相关论文
共 50 条
  • [1] Daratumumab for treatment of antibody-mediated rejection after ABO-incompatible kidney transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. SWISS MEDICAL WEEKLY, 2019, : 14S - 15S
  • [2] Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
    Spica, Davide
    Junker, Till
    Dickenmann, Michael
    Schaub, Stefan
    Steiger, Jurg
    Rufli, Tanja
    Halter, Jorg
    Hopfer, Helmut
    Holbro, Andreas
    Hirt-Minkowski, Patricia
    [J]. CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2019, 9 (03): : 149 - 157
  • [3] REVERSAL OF REFRACTORY ANTIBODY-MEDIATED REJECTION IN ABO-INCOMPATIBLE KIDNEY TRANSPLANTATION BY ECULIZUMAB
    Morath, C.
    Kirschfink, M.
    Waldherr, R.
    Becker, L. E.
    Kihm, L. P.
    Schaier, M.
    Schwenger, V.
    Schmidt, J.
    Hohenfellner, M.
    Leo, A.
    Opelz, G.
    Suesal, C.
    Zeier, M.
    [J]. TRANSPLANT INTERNATIONAL, 2011, 24 : 34 - 34
  • [4] ABO Antibody Titer and Risk of Antibody-Mediated Rejection in ABO-Incompatible Renal Transplantation
    Tobian, A. A. R.
    Shirey, R. S.
    Montgomery, R. A.
    Cai, W.
    Haas, M.
    Ness, P. M.
    King, K. E.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1247 - 1253
  • [5] Bortezomib Rescue of Acute Antibody-Mediated Rejection after ABO Incompatible Kidney Transplantation.
    Miura, Masayoshi
    Shimoda, Naohiko
    Fukuzawa, Nobuyuki
    Tanabe, Tatsu
    Nonomura, Katsuya
    Tamaki, Tohru
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 : 397 - 398
  • [6] Association between response to rituximab and antibody-mediated rejection in ABO-incompatible living kidney transplantation
    Maenosono, Ryoichi
    Unagami, Kohei
    Kakuta, Yoichi
    Furusawa, Miyuki
    Okumi, Masayoshi
    Azuma, Haruhito
    Ishida, Hideki
    Tanabe, Kazunari
    [J]. INTERNATIONAL JOURNAL OF UROLOGY, 2019, 26 (12) : 1114 - 1120
  • [7] Evaluation of Microvascular Inflammation in ABO-Incompatible Kidney Transplantation
    Ishihara, Hiroki
    Ishida, Hideki
    Unagami, Kohei
    Hirai, Toshihito
    Okumi, Masayoshi
    Omoto, Kazuya
    Shimizu, Tomokazu
    Tanabe, Kazunari
    [J]. TRANSPLANTATION, 2017, 101 (06) : 1423 - 1432
  • [8] Association between Response to Rituximab and Risk of Antibody-Mediated Rejection in ABO-Incompatible Living Kidney Transplantation
    Kakuta, Y.
    Okumi, M.
    Kanzawa, T.
    Unagami, K.
    Ishida, H.
    Tanabe, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 898 - 898
  • [9] Plasma cell-rich rejection accompanied by acute antibody-mediated rejection in a patient with ABO-incompatible kidney transplantation
    Furuya, Maiko
    Yamamoto, Izumi
    Kobayashi, Akimitsu
    Nakada, Yasuyuki
    Sugano, Naoki
    Tanno, Yudo
    Ohkido, Ichiro
    Tsuboi, Nobuo
    Yamamoto, Hiroyasu
    Yokoyama, Keitaro
    Yokoo, Takashi
    [J]. NEPHROLOGY, 2014, 19 : 31 - 34
  • [10] IMPACT OF INFECTIOUS COMPLICATIONS ON ANTIBODY-MEDIATED REJECTION AFTER ABO-INCOMPATIBLE KIDNEY TRANSPLANTATIONS
    Kwon, Hyunwook
    Kim, Young Hoon
    Kim, Dong Hyun
    Ko, Youngmin
    Jung, Joo Hee
    Han, Duck Jong
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 395 - 395